JPH09118624A5 - - Google Patents

Info

Publication number
JPH09118624A5
JPH09118624A5 JP1996197330A JP19733096A JPH09118624A5 JP H09118624 A5 JPH09118624 A5 JP H09118624A5 JP 1996197330 A JP1996197330 A JP 1996197330A JP 19733096 A JP19733096 A JP 19733096A JP H09118624 A5 JPH09118624 A5 JP H09118624A5
Authority
JP
Japan
Prior art keywords
composition
compound
tungsten
tungstate
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1996197330A
Other languages
English (en)
Japanese (ja)
Other versions
JPH09118624A (ja
Filing date
Publication date
Priority claimed from ES9501603A external-priority patent/ES2108642B1/es
Application filed filed Critical
Publication of JPH09118624A publication Critical patent/JPH09118624A/ja
Publication of JPH09118624A5 publication Critical patent/JPH09118624A5/ja
Pending legal-status Critical Current

Links

JP19733096A 1995-07-26 1996-07-26 真性糖尿病の経口処置用タングステン（ｖｉ）組成物 Pending JPH09118624A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9501603A ES2108642B1 (es) 1995-07-26 1995-07-26 Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
ES9501603 1995-07-26

Publications (2)

Publication Number Publication Date
JPH09118624A JPH09118624A (ja) 1997-05-06
JPH09118624A5 true JPH09118624A5 (enExample) 2004-08-12

Family

ID=8291317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19733096A Pending JPH09118624A (ja) 1995-07-26 1996-07-26 真性糖尿病の経口処置用タングステン（ｖｉ）組成物

Country Status (2)

Country Link
JP (1) JPH09118624A (enExample)
ES (1) ES2108642B1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2187276B1 (es) 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
WO2007014970A1 (es) * 2005-07-29 2007-02-08 Universidad De Barcelona Composiciones farmacéuticas que comprenden una sal de tungsteno (vi) para el tratamiento de trastornos neurodegenerativos, en particular alzheimer y esquizofrenia
CN100515428C (zh) * 2007-04-26 2009-07-22 暨南大学 钨酸锂在制药中的应用
ES2478696B1 (es) * 2012-12-21 2015-05-06 Universitat De Barcelona Sales de tungstato como agentes antiplaquetarios
ES2478790B1 (es) * 2013-01-22 2015-05-06 Oxolife, S. L. Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)
SI3173382T1 (sl) * 2014-07-21 2023-04-28 Oxolife, S. L. Volframove (VI) soli za stimuliranje plodnosti in reprodukcije ter za izboljšanje učinkovitosti tehnik asistirane reprodukcije

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025916A (ja) * 1983-07-21 1985-02-08 Tanaka Seinosuke 入浴水
JPS6025928A (ja) * 1983-07-21 1985-02-08 Tanaka Seinosuke 薬剤

Similar Documents

Publication Publication Date Title
CA2386690A1 (en) Pharmaceutical tramadol salts
JP2003520232A5 (enExample)
JP2003503454A5 (enExample)
JP2003531118A5 (enExample)
JP2006526031A5 (enExample)
ID22980A (id) Komposisi-komposisi farmasi untuk pelepasan zat-zat aktif yang dikontrol
WO2001092283A3 (en) Cobalamin compounds useful as cardiovascular agents and as imaging agents
JP2005500357A5 (enExample)
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
JP2006502187A5 (enExample)
JP2000159790A5 (enExample)
HK1042303A1 (zh) 新的化合物
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
ATE89547T1 (de) Dopamin-vorlaeufer.
JP2005508337A5 (enExample)
RU2003118411A (ru) Кристаллические производные 1-метилкарбапенема
EP1612208A3 (en) N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
RU2003100507A (ru) Фармацевтические композиции
WO2001000566A3 (en) Substituted phenoxyacetic acids
JPH09118624A5 (enExample)
JP2002509164A5 (enExample)
CA2270955A1 (en) Pharmaceutical composition containing morphinan derivative for treating drug dependence
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
JP2007527904A5 (enExample)
CA2005980A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation